JD HEALTH INTL LTD Net Assets
JD HEALTH INTL LTD net assets. Based on the latest financial reports, JD HEALTH INTL LTD (8ZN) has net assets worth €61.46 Billion EUR (≈ $71.85 Billion USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€84.17 Billion ≈ $98.41 Billion USD) and total liabilities (€22.72 Billion ≈ $26.56 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 8ZN shareholders equity momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €61.46 Billion |
| % of Total Assets | 73.01% |
| Annual Growth Rate | N/A |
| 5-Year Change | 50.73% |
| 10-Year Change | N/A |
| Growth Volatility | 3.92 |
Net Assets of JD HEALTH INTL LTD (2019–2025)
Net assets of JD HEALTH INTL LTD from 2019 to 2025. This chart illustrates how JD HEALTH INTL LTD's net assets have evolved over time, based on quarterly financial data. See net asset quality index of JD HEALTH INTL LTD to measure how much of total assets are equity-financed.
Annual Net Assets for JD HEALTH INTL LTD (2019–2025)
The table below shows the annual net assets of JD HEALTH INTL LTD from 2019 to 2025. For live market cap and overall valuation, see market cap of JD HEALTH INTL LTD.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €60.07 Billion ≈ $70.23 Billion |
+8.75% |
| 2024-12-31 | €55.24 Billion ≈ $64.58 Billion |
+11.89% |
| 2023-12-31 | €49.37 Billion ≈ $57.72 Billion |
+10.24% |
| 2022-12-31 | €44.78 Billion ≈ $52.36 Billion |
+12.37% |
| 2021-12-31 | €39.85 Billion ≈ $46.59 Billion |
+1.54% |
| 2020-12-31 | €39.25 Billion ≈ $45.89 Billion |
+8650.91% |
| 2019-12-31 | €-459.03 Million ≈ $-536.66 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to JD HEALTH INTL LTD's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 660249000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
JD HEALTH INTL LTD Net Assets Breakdown (December 2025)
JD HEALTH INTL LTD net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €68.04 Billion | 113.27% |
| Total Equity | €60.07 Billion | 100.00% |
JD HEALTH INTL LTD Competitors by Market Cap
The table below lists competitors of JD HEALTH INTL LTD ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cipla Limited
NSE:CIPLA
|
$12.05 Billion |
|
Renaissancere Holdings Ltd
NYSE:RNR
|
$12.05 Billion |
|
Demant A/S
CO:DEMANT
|
$12.06 Billion |
|
Mueller Industries Inc
NYSE:MLI
|
$12.07 Billion |
|
Nextpower Inc.
NASDAQ:NXT
|
$12.04 Billion |
|
Lingyi iTech Guangdong Co
SHE:002600
|
$12.03 Billion |
|
MAPFRE S.A.ADR 2 / EO-10
F:CMA
|
$12.03 Billion |
|
ZTO Express (Cayman) Inc
F:ZTOA
|
$12.02 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JD HEALTH INTL LTD's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 55,231,156,000 to 60,071,824,000, a change of 4,840,668,000 (8.8%).
- Net income of 5,375,405,000 contributed positively to equity growth.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €5.38 Billion | +8.95% |
| Other Changes | €-534.74 Million | -0.89% |
| Total Change | €- | 8.76% |
Book Value vs Market Value Analysis
This analysis compares JD HEALTH INTL LTD's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.23x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | €-0.15 | €4.30 | x |
| 2020-12-31 | €12.33 | €4.30 | x |
| 2021-12-31 | €12.48 | €4.30 | x |
| 2022-12-31 | €14.08 | €4.30 | x |
| 2023-12-31 | €15.48 | €4.30 | x |
| 2024-12-31 | €17.27 | €4.30 | x |
| 2025-12-31 | €18.77 | €4.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently JD HEALTH INTL LTD utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.95%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.32%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 1.36x
- Recent ROE (8.95%) is above the historical average (-3.56%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -8.96% | 1.25x | 0.00x | €-925.90 Million |
| 2020 | -43.91% | -88.92% | 0.44x | 1.12x | €-21.16 Billion |
| 2021 | -2.69% | -3.50% | 0.64x | 1.20x | €-5.06 Billion |
| 2022 | 0.85% | 0.81% | 0.76x | 1.37x | €-4.10 Billion |
| 2023 | 4.34% | 4.00% | 0.83x | 1.30x | €-2.79 Billion |
| 2024 | 7.54% | 7.16% | 0.82x | 1.29x | €-1.36 Billion |
| 2025 | 8.95% | 7.32% | 0.90x | 1.36x | €-631.78 Million |
Industry Comparison
This section compares JD HEALTH INTL LTD's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $3,419,417,600
- Average return on equity (ROE) among peers: 1.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JD HEALTH INTL LTD (8ZN) | €61.46 Billion | 0.00% | 0.37x | $12.04 Billion |
| IRWIN NATURALS INC. (97X) | $23.12 Million | 37.27% | 1.04x | $606.63K |
| Redcare Pharmacy NV (RDC) | $232.76 Million | -15.58% | 0.84x | $973.54 Million |
| Redcare Pharmacy NV (RDC) | $18.08 Million | -15.66% | 0.42x | $901.38 Million |
| SHOP APOTH. UNSP.ADR/010 (SAE1) | $509.97 Million | -8.92% | 0.97x | $1.07 Billion |
| ALIB.HL.INF.TEC.UNSP.ADR (TWYA) | $16.31 Billion | 8.78% | 0.30x | $8.42 Billion |
About JD HEALTH INTL LTD
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. Th… Read more